20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
- 23 February 2007
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 107 (3), 687-717
- https://doi.org/10.1021/cr0502504
Abstract
No abstract availableThis publication has 232 references indexed in Scilit:
- Crystal Structure of TET Protease Reveals Complementary Protein Degradation Pathways in ProkaryotesJournal of Molecular Biology, 2005
- Fertilization and InsP3-induced Ca2+ release stimulate a persistent increase in the rate of degradation of cyclin B1 specifically in mature mouse oocytesDevelopmental Biology, 2004
- Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus SalinosporaAngewandte Chemie-International Edition, 2003
- Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitorJournal of Molecular Biology, 2001
- Lactacystin, a Specific Inhibitor of the Proteasome, Inhibits Human Platelet Lysosomal Cathepsin A-like EnzymeBiochemical and Biophysical Research Communications, 1997
- Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexesJournal of Molecular Biology, 1997
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytesCurrent Biology, 1995
- Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitorBiochemical and Biophysical Research Communications, 1991
- Thermodynamics of Chelation. I. The Statistical Factor in Chelate Ring Formation1Journal of the American Chemical Society, 1953